Format

Send to

Choose Destination
Am J Physiol Regul Integr Comp Physiol. 2017 Dec 1;313(6):R730-R739. doi: 10.1152/ajpregu.00284.2017. Epub 2017 Sep 20.

Fluid replacement modulates oxidative stress- but not nitric oxide-mediated cutaneous vasodilation and sweating during prolonged exercise in the heat.

Author information

1
Human and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada.
2
Faculty of Health and Sports Science, University of Tsukuba, Tsukuba, Japan.
3
Thoracic Surgery and Critical Care Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada.
4
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; and.
5
Departments of Medicine, Cardiac Sciences and Community Health Sciences, Faculties of Medicine and Kinesiology University of Calgary, Calgary, Alberta, Canada.
6
Human and Environmental Physiology Research Unit, University of Ottawa, Ottawa, Canada; gkenny@uottawa.ca.

Abstract

The roles of nitric oxide synthase (NOS), reactive oxygen species (ROS), and angiotensin II type 1 receptor (AT1R) activation in regulating cutaneous vasodilation and sweating during prolonged (≥60 min) exercise are currently unclear. Moreover, it remains to be determined whether fluid replacement (FR) modulates the above thermoeffector responses. To investigate, 11 young men completed 90 min of continuous moderate intensity (46% V̇o2peak) cycling performed at a fixed rate of metabolic heat production of 600 W (No FR condition). On a separate day, participants completed a second session of the same protocol while receiving FR to offset sweat losses (FR condition). Cutaneous vascular conductance (CVC) and local sweat rate (LSR) were measured at four intradermal microdialysis forearm sites perfused with: 1) lactated Ringer (Control); 2) 10 mM NG-nitro-l-arginine methyl ester (l-NAME, NOS inhibition); 3) 10 mM ascorbate (nonselective antioxidant); or 4) 4.34 nM losartan (AT1R inhibition). Relative to Control (71% CVCmax at both time points), CVC with ascorbate (80% and 83% CVCmax) was elevated at 60 and 90 min of exercise during FR (both P < 0.02) but not at any time during No FR (all P > 0.31). In both conditions, CVC was reduced at end exercise with l-NAME (60% CVCmax; both P < 0.02) but was not different relative to Control at the losartan site (76% CVCmax; both P > 0.19). LSR did not differ between sites in either condition (all P > 0.10). We conclude that NOS regulates cutaneous vasodilation, but not sweating, irrespective of FR, and that ROS influence cutaneous vasodilation during prolonged exercise with FR.

KEYWORDS:

angiotensin II; fluid replacement; nitric oxide; prolonged exercise; reactive oxygen species

PMID:
28931548
PMCID:
PMC5814697
DOI:
10.1152/ajpregu.00284.2017
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center